XCL2 encodes for a protein that enhances chemotactic activity for lymphocytes and downregulation of XCL2 has been shown to be associated with good prognosis in patients with breast cancer (Teschendorff et al, 2007; Teschendorff and Caldas, 2008). Here, XCL2 is linked to breast carcinoma.